Name Development Level Target Family
Vascular endothelial growth factor receptor 2 Tclin Kinase
Name Description
ramucirumab a fully human monoclonal antibody developed to specifically inhibit VEGFR-2
TCRDv4.6.0
DrugCentral Indication
DrugCentral
ramucirumab